Jfs Wealth Advisors, LLC Roivant Sciences Ltd. Transaction History
Jfs Wealth Advisors, LLC
- $1.69 Billion
- Q3 2025
A detailed history of Jfs Wealth Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 61 shares of ROIV stock, worth $1,274. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61Holding current value
$1,274% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
365Shares Held
458MCall Options Held
8.66MPut Options Held
761K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.25 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$934 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$811 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$739 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$716 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.7B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...